The latest price target for Labcorp Holdings (NYSE:LH) was reported by Evercore ISI Group on April 8, 2026. The analyst firm set a price target for $300.00 expecting LH to rise to within 12 months (a possible 18.05% upside). 21 analyst firms have reported ratings in the last year.

The latest analyst rating for Labcorp Holdings (NYSE:LH) was provided by Evercore ISI Group, and Labcorp Holdings maintained their outperform rating.

The last upgrade for Labcorp Holdings Inc happened on March 4, 2025 when Citigroup raised their price target to $300. Citigroup previously had a neutral for Labcorp Holdings Inc.

There is no last downgrade for Labcorp Holdings.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Labcorp Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Labcorp Holdings was filed on April 8, 2026 so you should expect the next rating to be made available sometime around April 8, 2027.

While ratings are subjective and will change, the latest Labcorp Holdings (LH) rating was a maintained with a price target of $280.00 to $300.00. The current price Labcorp Holdings (LH) is trading at is $254.12, which is out of the analyst’s predicted range.